| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
| 05/28/2009 | WO2009067597A1 4- (or 5-) substituted catechol derivatives |
| 05/28/2009 | US20090137594 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090136425 Contrast agents |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101440049A Cleaning method for synthesizing N,N'-diphenylurea |
| 05/27/2009 | CN100490799C Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/22/2009 | WO2009063804A1 Process for production of n-carbamoyl-tert-leucine |
| 05/21/2009 | US20090131718 Crystallized diacetylenic indicator compounds and methods of preparing the compounds |
| 05/21/2009 | US20090130085 Amidino-Compounds for Stabilizing Factor VII Polypeptide Formulations |
| 05/20/2009 | CN101437862A Hydrophilic stain release agents |
| 05/20/2009 | CN101437804A Dibenzyl amine compounds and derivatives |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009039361A3 Process for the preparation of (s)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid |
| 05/14/2009 | US20090124686 Gsk-3 inhibitors |
| 05/13/2009 | EP1641746A4 Polyurea polymers from secondary polyether polyamines |
| 05/13/2009 | EP1565429B1 Diaryl ureido derivatives and their medical use |
| 05/13/2009 | CN101432268A Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor |
| 05/12/2009 | US7531576 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 05/12/2009 | CA2367984C Synergistic insecticidal compositions |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/06/2009 | EP1554240B1 Substituted tetralins and indanes and their use |
| 05/06/2009 | CN101426887A Process for the treatment of a product stream |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 04/30/2009 | WO2009053443A2 Indane compounds |
| 04/30/2009 | WO2006014405A3 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | CN101421257A Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | CA2361716C Method of preparing alkylated salicylamides |
| 04/28/2009 | CA2339765C Compounds and compositions for delivering active agents |
| 04/23/2009 | WO2009050041A1 Novel carbamoylglycine derivatives |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | WO2006071940A3 Enzyme modulators and treatments |
| 04/23/2009 | US20090105258 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 04/23/2009 | CA2702950A1 Methods and compounds for modulating cannabinoid activity |
| 04/22/2009 | EP1851193B1 Hiv protease inhibitors |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099021 Urea phosphite fungicide |
| 04/15/2009 | EP2046734A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 04/15/2009 | EP2003104A9 Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
| 04/15/2009 | EP1809630B1 4-amino-5-oxo-8-phenyl-5h-pyrido-[2,3-d]-pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 04/15/2009 | CN101407477A Method for synthesizing diphenylurea from urea and aniline |
| 04/15/2009 | CN100478330C Method of preparing 3-(3,4-dichloro-phenyl)-urea |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/09/2009 | WO2009045830A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| 04/09/2009 | WO2009024493A3 Polymerizable alkenyl isocyanate and polymers comprising said isocyanate |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/09/2009 | CA2701120A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| 04/08/2009 | EP1430023B1 Substituied urea retinoid agonists ii |
| 04/08/2009 | CN101405264A Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 04/08/2009 | CN100475784C Continuous process for producing MDI allophanate |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514582 Cardiac ANTIARRHYTHMIA AGENTS; atrial fibrillation or atrial flutter; Kv1.5 potassium channel blockers; |
| 04/02/2009 | WO2009041482A1 Acetylene compound |
| 04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
| 04/01/2009 | EP2041103A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 04/01/2009 | CN101400647A Method for nitrating isourea |
| 04/01/2009 | CN100473644C 9-substituted minocycline compounds |
| 03/31/2009 | CA2292549C Use of colchinol derivatives as vascular damaging agents |
| 03/26/2009 | US20090082456 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082423 Soluble epoxide hydrolase inhibitors |
| 03/25/2009 | CN100471838C VLA-4 inhibitors |
| 03/24/2009 | US7507828 Such as quinoline-8-carboxylic acid [5-(2-mercapto-acetylamino)-pentyl]-amide; increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases |
| 03/19/2009 | WO2009035928A1 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009034308A2 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process |
| 03/19/2009 | US20090076110 An amine salt of nitric acid and aginine, beta alanine, agmatine, citrulline, creatine, glutamine, L-histidine, isoleucine, leucine,norvaline, or ornithine; vasodilation; metabolism of mucle protein;exercise |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090074746 Compounds to treat alzheimer's disease |
| 03/19/2009 | CA2698795A1 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process |
| 03/18/2009 | EP1888514B1 Salts of substituted allophanates and their use in drugs |
| 03/18/2009 | CN101386600A Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same |
| 03/18/2009 | CN100469761C Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 03/17/2009 | US7504538 4-[3-phenyl-1-(6-phenylhexyl)ureido]butyramide; cannabinoid receptor modulators |
| 03/17/2009 | US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/12/2009 | WO2009030752A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them |
| 03/12/2009 | WO2009030746A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 03/12/2009 | US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | CA2698838A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 03/12/2009 | CA2698304A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them |
| 03/11/2009 | CN101384175A Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| 03/05/2009 | WO2009001356A3 Acyl-urea derivatives and uses thereof |
| 03/05/2009 | WO2008156816A8 Renin inhibitors |
| 03/05/2009 | US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/04/2009 | EP2029539A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 03/04/2009 | CN101379026A Process for production of O-methyl-n-nitroisourea |